中国卫生标准管理
中國衛生標準管理
중국위생표준관리
CHINA HEALTH STANDARD MANAGEMENT
2015年
8期
127-128
,共2页
脊髓空洞症%分流手术%疗效分析
脊髓空洞癥%分流手術%療效分析
척수공동증%분류수술%료효분석
Syringomyelia%Shunt operation%Curative effect analysis
目的:分析通过分流手术治疗脊髓空洞症的患者的临床资料,研究分流手术的临床效果。方法选取我院2012年1月~2014年12月收治的40例脊髓空洞症患者,在进行详细的检查后对其进行分流手术,并在术后3年内进行跟踪随访,确定患者的康复效果。24例为外伤后脊髓空洞症,16例为蛛网膜炎导致的脊髓空洞症。结果28例患者经治疗有明显改善,临床症状基本消失;10例患者较术前有所改善,但症状依旧存在;1例患者的临床症状无明显变化;1例患者加重,治疗有效率达95%。结论通过分流手术治疗脊髓空洞症的患者在手术后神经功能得到明显的改善,空洞复发率低。可见分流手术是目前临床上治疗脊髓空洞症的有效途径。
目的:分析通過分流手術治療脊髓空洞癥的患者的臨床資料,研究分流手術的臨床效果。方法選取我院2012年1月~2014年12月收治的40例脊髓空洞癥患者,在進行詳細的檢查後對其進行分流手術,併在術後3年內進行跟蹤隨訪,確定患者的康複效果。24例為外傷後脊髓空洞癥,16例為蛛網膜炎導緻的脊髓空洞癥。結果28例患者經治療有明顯改善,臨床癥狀基本消失;10例患者較術前有所改善,但癥狀依舊存在;1例患者的臨床癥狀無明顯變化;1例患者加重,治療有效率達95%。結論通過分流手術治療脊髓空洞癥的患者在手術後神經功能得到明顯的改善,空洞複髮率低。可見分流手術是目前臨床上治療脊髓空洞癥的有效途徑。
목적:분석통과분류수술치료척수공동증적환자적림상자료,연구분류수술적림상효과。방법선취아원2012년1월~2014년12월수치적40례척수공동증환자,재진행상세적검사후대기진행분류수술,병재술후3년내진행근종수방,학정환자적강복효과。24례위외상후척수공동증,16례위주망막염도치적척수공동증。결과28례환자경치료유명현개선,림상증상기본소실;10례환자교술전유소개선,단증상의구존재;1례환자적림상증상무명현변화;1례환자가중,치료유효솔체95%。결론통과분류수술치료척수공동증적환자재수술후신경공능득도명현적개선,공동복발솔저。가견분류수술시목전림상상치료척수공동증적유효도경。
Objective To analyze the clinical data of shunting operation through the treatment of syringomyelia patients,clinical study on the efect of shunt operation. Methods40 patients with syringomyelia patients in our hospital in January 2012 to December 2014 were enrolment,in a detailed examination after the shunt operation,and in postoperative 3 years folow-up,determine the rehabilitation effect of patients. 24 cases of post-traumatic syringomyelia,16 cases of syringomyelia caused as arachnoiditis.Results 28 patients were treated and had obvious improvement,clinical symptoms disappeared; 10 patients with preoperative symptoms improved,but stil exist, no significant changes in the clinical symptoms of 1 patients; 1 patients were increased,the efective rate was 95%.ConclusionThrough the shunting operation treatment of syringomyelia patients improved obviously in neural function after operation,empty low recurrence rate. Visible shunting operation is an efective way to the current clinical treatment of syringomyelia,is worth the clinical promotion.